1. Home
  2. TEX vs ACAD Comparison

TEX vs ACAD Comparison

Compare TEX & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEX
  • ACAD
  • Stock Information
  • Founded
  • TEX 1933
  • ACAD 1993
  • Country
  • TEX United States
  • ACAD United States
  • Employees
  • TEX N/A
  • ACAD N/A
  • Industry
  • TEX Construction/Ag Equipment/Trucks
  • ACAD Biotechnology: Pharmaceutical Preparations
  • Sector
  • TEX Industrials
  • ACAD Health Care
  • Exchange
  • TEX Nasdaq
  • ACAD Nasdaq
  • Market Cap
  • TEX 3.1B
  • ACAD 3.5B
  • IPO Year
  • TEX N/A
  • ACAD 2004
  • Fundamental
  • Price
  • TEX $51.44
  • ACAD $23.27
  • Analyst Decision
  • TEX Buy
  • ACAD Buy
  • Analyst Count
  • TEX 9
  • ACAD 18
  • Target Price
  • TEX $51.44
  • ACAD $27.71
  • AVG Volume (30 Days)
  • TEX 822.9K
  • ACAD 1.8M
  • Earning Date
  • TEX 07-31-2025
  • ACAD 08-05-2025
  • Dividend Yield
  • TEX 1.32%
  • ACAD N/A
  • EPS Growth
  • TEX N/A
  • ACAD N/A
  • EPS
  • TEX 3.67
  • ACAD 1.37
  • Revenue
  • TEX $5,064,000,000.00
  • ACAD $996,283,000.00
  • Revenue This Year
  • TEX $4.95
  • ACAD $13.28
  • Revenue Next Year
  • TEX $4.61
  • ACAD $11.06
  • P/E Ratio
  • TEX $14.05
  • ACAD $17.00
  • Revenue Growth
  • TEX N/A
  • ACAD 22.42
  • 52 Week Low
  • TEX $31.53
  • ACAD $13.40
  • 52 Week High
  • TEX $68.09
  • ACAD $25.23
  • Technical
  • Relative Strength Index (RSI)
  • TEX 58.97
  • ACAD 64.68
  • Support Level
  • TEX $48.14
  • ACAD $22.09
  • Resistance Level
  • TEX $50.84
  • ACAD $22.84
  • Average True Range (ATR)
  • TEX 1.63
  • ACAD 0.69
  • MACD
  • TEX -0.17
  • ACAD 0.09
  • Stochastic Oscillator
  • TEX 50.38
  • ACAD 98.82

About TEX Terex Corporation

Terex Corp is a manufacturer of materials processing machinery, waste and recycling solutions, mobile elevating work platforms (MEWPs), and equipment for the electric utility industry. The company designs builds, and supports products used in maintenance, manufacturing, energy, waste and recycling, minerals and materials management, construction, and the entertainment industry. The products are manufactured in North America, Europe, and Asia Pacific and sold all over the world. The company reports business in the following segments: (i) Materials Processing, (ii) Aerial Work Platforms, and (iii) Environmental Solutions Group.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: